Silencing poly (ADP-Ribose) glycohydrolase (PARG) expression inhibits growth of human colon cancer cells in vitro via PI3K/Akt/NFκ-B pathway

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 191-199

  Fauzee, Nilufer Jasmine Selimah ^a   Li, Qiaozhuan ^a   Wang, Ya Lan ^a   Pan, Juan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

NF B; PARG; PARP; PI3K Akt pathway

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; POLY ADP RIBOSE GLYCOHYDROLASE GENE; POLY ADP RIBOSE POLYMERASE GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GENE;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; COLONIC NEOPLASMS; ELAFIN; FLOW CYTOMETRY; GTPASE-ACTIVATING PROTEINS; HUMANS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84863482663     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9428-1     Document Type: Article

References (37)

1. 2-induced cell death. Biochem J 396:419-429
2. Koh DW, Lawler AM, Poitras MF et al (2004) Failure to degrade poly (ADP-ribose) increased sensitivity to cytotoxicity and early embryonic lethality. PNAS 101:17699-17704
3. Poitras MF, Koh DW, Yu SW et al (2007) Spatial and functional relationship between poly (ADP-ribose) polymerase-1 and Poly (ADP-ribose) glycohydrolase in the brain. Neuroscience 148:198-211
4. Meyer RG, Meyer-Ficca ML, Jacobson EL, Jacobson MK (2003) Human poly (ADP-ribose) glycohydrolase (PARG) gene and the common promoter sequence it shares with inner mitochondrial membrane translocase 23 (TIM23). Gene 314:181-190
5. Fisher AEO, Hochegger H, Takeda S et al (2007) Poly (ADPribose) polymerase 1 accelerates single-strand break repair in concert with poly (ADP-ribose) glycohydrolase. Mol Cell Biol 27:5597-5605
6. Cohausz O, Blenn C, Malanga M et al (2008) The roles of poly (ADP-ribose)-metabolising enzymes in alkylation-induced cell death. Cell Mol Life Sci 65:644-655
7. Frizzell KM, Gamble MJ, Berrocal JG (2009) Global analysis of transcriptional regulation by poly (ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem 284:33926-33938
8. Gagne JP, Moreel X, Gagne P et al (2009) Proteomic investigation of phosphorylation sites in poly (ADP-ribose) polymerase-1 and poly (ADP-ribose) glycohydrolase. J Proteome Res 8:1014-1029
9. Palfi A, Toth A, Kulcsar G et al (2005) The role of akt and mitogen-activated protein kinase systems in the protective effect of poly (ADP-Ribose) polymerase inhibition in langendorff perfused and in isoproterenol-damaged rat hearts. JPET 315:273-282
10. Tapodi A, Debreceni B, Hanto K et al (2005) Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase-1 inhibition in oxidative stress. JBC 280:35767-35775
11. Veres B, Gallyas F Jr, Varbiro G et al (2003) Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 65:1373-1382
12. LoPiccolo J, Granville CA, Gills JJ et al (2007) Targeting Akt in cancer therapy. Anti-cancer drugs 18:861-874
13. Bader AG, Khang S, Li Z et al (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5:921-929
14. Li B, Cheung PY, Wang X et al (2007) Id-1 activation of PI3K/Akt/NFkB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28:2313-2320
15. Asano T, Yao Y, Zhu J et al (2004) The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells. Oncogene 23:8571-8580
16. Kane LP, Shapiro VS, Stokoe D et al (1999) Induction of NFkappaB by the Akt/PKB kinase. Curr Biol 9:601-604
17. Romashkova JA, Makarov SS (1999) NF-kappaB is a target of AKT in antiapoptotic PDGF signalling. Nature 401:86-90
18. Virag L, Szabo C (2002) The therapeutic potential of poly (ADPribose) polymerase inhibitors. Pharmacol Rev 54:375-429
19. Li M, Threadgill MD, Wang YL, Cai L, Lin X (2009) A poly (ADP-ribose) polymerase inhibition down-regulates expression of metastasis-related genes in CT26 colon carcinoma cells. Pathobiology 76:108-116
20. Lin L, Li J, Wang YL et al (2009) Relationship of PARG with colorectal carcinoma PARP, VEGF and b-FGF in colorectal carcinoma. Chin J Cancer Res 21:135-141
21. Tulin A, Naumova NM, Menon AK et al (2006) Drosophilia poly (ADP-Ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing. Genetics 172:363-371
22. Erdelyi K, Bai P, Kovacs I et al (2009) Dual role of poly(ADPribose) glycohydrolase in the regulation of cell death in oxidatively stresses A549 cells. FASEB 23:3553-3563
23. Fauzee NJS, Juan P, Wang YL (2010) PARP and PARG inhibitorsnew therapeutic targets in cancer treatment. Pathol Oncol Res 4:469-478
24. Karin M, Cao Y, Greten FR et al (2002) NFκB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310
25. Veres B, Radnai B, Gallyas F et al (2004) Regulation of kinase cascades and transcripition factors by a poly (ADP-Ribose) polymerase-1 inhibitor, 4-Hydroxyquinazoline, in lipopolysaccharideinduced inflammation in mice. JPET 310:247-255
26. Kovacs K, Toth A, Deres P et al (2006) Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochem Pharmacol 71:441-452
27. Bar-Shai M, Carmeli E, Reznick AZ (2005) The role of NF-κB in protein breakdown in immobilization, aging, and exercise from basic processes to promotion of health. Ann NY Acad Sci 1057:431-447
28. Cai D, Frantz JD, Tawa NE et al (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119:285-298
29. Xian L, Guang-jie D, Wang Y et al (2010) Expressions of Poly (ADP-ribose) Glycohydrolase (PARG) and membrane Type1 Matrix Metalloproteinase (MT1-MMP) in Colorectal Carcinoma. Chin J Cancer Res 22:186-193
30. Olashaw NE, Kowalik TF, Huang EH et al (1992) Induction of NF-KB-Like Activity by Platelet-Derived Growth Factor in Mouse Fibroblasts. Mol Biol Cell 3:1131-1139
31. Bushdid PB, Chen CL, Brantley DM et al (2001) NF-κB mediates FGF signal regulation of msx-1 expression. Dev Biol 237:107-115
32. Hayden MS, West AP, Ghosh S (2006) NF-κB and the immune response. Oncogene 119:6758-6780
33. Bai D, Ueno L, Vogt PK (2009) Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt. Int J Cancer 125:2863-2870
34. Guha M, Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. JBC 277:32124-32132
35. Tamizhselvi R, Sun J, Koh YH et al (2009) Effect of hydrogen sulfide on the phosphatidylinositol 3-kinase-protein kinase B pathway and on caerulein-induced cytokine production in isolated mouse pancreatic acinar cells. JPET 329:1166-1178
36. Zhou H, Qian J, Li C et al (2011) Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3Kdependent mechanism. Cardiovasc Res 89:109-118
37. Zhao L, Lee JY, Hwang DH (2008) The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kB pathway. Biochempharm 75:1515-1525